Literature DB >> 11058487

Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence.

J S Fowler1, G J Wang, N D Volkow, D Franceschi, J Logan, N Pappas, C Shea, R R MacGregor, V Garza.   

Abstract

OBJECTIVE: The authors' goal was to replicate a previous finding that smokers have lower brain monoamine oxidase B (MAO-B) levels than comparison nonsmoking subjects and to determine if levels recover after overnight cigarette abstinence.
METHOD: Brain MAO-B levels were measured by means of positron emission tomography in six smokers who were scanned twice: 11.3 hours (baseline) and 10 minutes after smoking one cigarette.
RESULTS: Average MAO-B levels in smokers in the present study were similar to those found in the previous study and averaged 39% (SD=17) lower than those found in a comparison group of nonsmokers. Brain MAO-B levels did not differ between baseline levels and 10 minutes after smoking.
CONCLUSIONS: This study reinforces the need to investigate whether MAO-B inhibition may account for some of the behavioral and epidemiological features of smoking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058487     DOI: 10.1176/appi.ajp.157.11.1864

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

Review 1.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

Review 2.  Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

Authors:  Jeffrey H Meyer; Simon Cervenka; Min-Jeong Kim; William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Lancet Psychiatry       Date:  2020-10-21       Impact factor: 27.083

Review 3.  Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Authors:  Luis M Tuesta; Christie D Fowler; Paul J Kenny
Journal:  Biochem Pharmacol       Date:  2011-06-29       Impact factor: 5.858

4.  A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.

Authors:  Ivan Berlin; Ian M Hunneyball; Doris Greiling; Stephen P Jones; Hermann Fuder; Hans-Detlev Stahl
Journal:  Psychopharmacology (Berl)       Date:  2012-03-27       Impact factor: 4.530

Review 5.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

Review 6.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence.

Authors:  Michael N Smolka; Henning Budde; Anne C Karow; Lutz G Schmidt
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

8.  Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans.

Authors:  Andrea M Dlugos; Abraham A Palmer; Harriet de Wit
Journal:  J Neural Transm (Vienna)       Date:  2009-08-06       Impact factor: 3.575

9.  Psychological Characteristics in Patients during Treatment for Tobacco Dependence.

Authors:  Akiko Matsuda; Junichi Hasegawa; Xinhui Wang; Satoshi Tsuno; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2015-08-18       Impact factor: 1.641

10.  Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.

Authors:  Jean-Marie Launay; Muriel Del Pino; Gilles Chironi; Jacques Callebert; Katell Peoc'h; Jean-Louis Mégnien; Jacques Mallet; Alain Simon; Francine Rendu
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.